S hares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach after U.S.

Drugmakers unveil cancer drug data at the ASCO annual meeting, while Amazon Pharmacy announces new features for caregivers, ...

A colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

Leading vaccine makers like Eli Lilly and Co. (NYSE: LLY), Pfizer Inc. (NYSE: PFE), and AstraZeneca plc (NASDAQ: AZN) may have faded from the spotlight since the peak of the COVID-19 pandemic ...

Recent health news includes a promising AstraZeneca pill for breast cancer treatment, Pfizer and Arvinas' experimental drug ...

Pfizer’s Chinese drug acquisition ... Expect a mob of Wall Street analysts and investors. AstraZeneca’s plenary streak continues: This is the seventh consecutive year that AstraZeneca has ...

The company is already working with multiple large hospitals in the U.S. and Israel, as well as drug companies, including AstraZeneca and Pfizer. Promise Bio is now emerging from stealth with a ...

Camizestrant will reach blockbuster status in 2030 with total sales worth $1.1 billion, according to GlobalData’s analyst ...

AstraZeneca received the harshest censure in the latest set of cases, taking a telling-off over one of its own posts, while Pfizer escaped with a slap on the wrist after its employees got too ...

Pfizer acquired a rival ADC, which entered the clinic just after AZD8205, as part of its takeover of Seagen. In the heavily pretreated study population, AstraZeneca saw nine partial responses ...

Given this evolving environment, now is the time for investors to consider the strengths and opportunities presented by Eli Lilly, Pfizer, and AstraZeneca. Here's why these companies remain ...